CRU on Demand
Clinilabs’ Phase 1 group provides sponsors with a unique clinical research unit (CRU) on Demand offering. When a CRU facility is needed for studies in rare patient population studies, we work with sponsors to identify investigators in the NY and NJ region who have access to such specialty populations, but who may not have access to inpatient research facilities.
Principal investigators can perform the outpatient portion of a clinical trial at their offices or clinics and admit to Clinilabs’ Phase 1 unit for the inpatient portion of the trial. We have used this collaborative model successfully in a variety of rare disorders.
The greatest joy in life is to accomplish. It is the getting, not the having. It is the giving, not the keeping.
The cures we want aren’t going to fall from the sky. We have to get ladders and climb up and get them.
Drugs don’t work in patients who don’t take them.
Good information is the best medicine.
There is so much more to be done; the patients are waiting.
The pace of discovery is going unbelievably fast.
I must say, I spend a lot of my time these days trying to persuade people that controlled trials are the only way to get information that’s reliable about drugs.
One never notices what has been done; one can only see what remains to be done.
Advances in drug development have led to greater improvement in the quality of human life than advances in all other fields combined.
I am not accustomed to saying anything with certainty after only one or two observations.
Let me tell you the secret that has led me to my goal. My strength lies solely in my tenacity.
One sometimes finds what one is not looking for.
The reward for work well done is the opportunity to do more.
The best way to predict the future is to invent it.
I have no ideology. My ideology is health.
It is easy to get a thousand prescriptions, but hard to get one single remedy.
I trust I may be enabled in the treatment of patients always to act with a single eye to their good.
Without drugs, physicians would struggle to find relevance, and patients would suffer without hope.
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
If you think compliance is expensive, try non-compliance.
All truths are easy to understand once they are discovered; the point is to discover them.